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Wild animals
a  b  s  t  r a  c t
In  recent  years,  several  emerging  zoonotic  vector-borne  infections  with  potential impact
on human health have  been  identified  in Europe, including tularaemia, caused  by  Fran-
cisella  tularensis. This  remarkable  pathogen, one  of the  most virulent microorganisms
currently  known,  has been  detected  in increasingly  new settings and  in a wide range  of
wild  species, including lagomorphs,  rodents, carnivores,  fish  and  invertebrate arthropods.
Also, a renewed  concern has  arisen with  regard  to  F.  tularensis: its potential use by  bioter-
rorists.  Based on  the  information published concerning  the  latest  outbreaks,  the  aim of this
paper is  to  review the  main features of the  agent,  its biology,  immunology and  epidemiol-
ogy.  Moreover,  special focus  will be  given to zoonotic  aspects of the  disease,  as tularaemia
outbreaks  in  human populations have been frequently  associated  with  disease  in animals.
© 2014 Elsevier Ltd. All rights reserved.
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